ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹1296 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 4.08% | 2.65% |
| 6 Month | 2.31% | 4.07% |
| 1 Year | -2.21% | 0.66% |
| 3 Year | 19.54% | 22.03% |
| 5 Year | - | 17.93% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | 1.25% | 1.96% |
| 1 Year | 4.32% | 8.61% |
| 3 Year | 18.64% | 20.94% |
| 5 Year | - | 18.6% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 18.94% | 9.76% |
| 3 Year | 20.21% | 18.6% |
| 5 Year | - | 15.32% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 15.65% | 16.05% |
| Sharp | 0.78% | 0.90% |
| Beta | 0.95% | 0.98% |
| Alpha | -2.36% | -0.49% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.56 | 4.14 |
| Large Cap | 29.45 | 25.14 |
| Mid Cap | 37.33 | 37.44 |
| Small Cap | 29.66 | 33.28 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.52 | 1.72 |
| Healthcare | 91.78 | 94.07 |
| Basic Materials | 3.67 | 2.64 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | 1.58 |
Top Comparisons
Kotak Equity Savings Fund - Regular - Growth
3Y Returns11.88%
Aditya Birla Sun Life Equity Savings Fund - Regular Plan - Growth
3Y Returns9.26%
Templeton India Value Fund - Growth Plan
3Y Returns18.12%
Aditya Birla Sun Life Value Fund - Growth Option
3Y Returns20.18%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns7.47%
HSBC Corporate Bond Fund - Regular Growth
3Y Returns7.9%
ICICI Prudential Large & Mid Cap Fund - Growth
3Y Returns21.87%
Canara Robeco Large and Mid Cap Fund - Regular Plan - Growth Option
3Y Returns16.69%